| Lundbeck (Schweiz) AG - Abilify Maintena 400 mg, Depot-Injektionssuspension in einer Fertigspritze | | 65774 | | 01 | | Abilify Maintena 400 mg | | Depot-Injektionssuspension in einer Fertigspritze | | N05AX12 | | Aripiprazole | | 15.03.2016 | | |
| | Composition | | Praeparatio cryodesiccata: aripiprazolum 400 mg ut aripiprazolum monohydricum, carmellosum natricum, mannitolum, natrii dihydrogenophosphas monohydricus, natrii hydroxidum, ad pulverem.
Solvens: aqua ad iniectabile.
Solutio reconstituta: aripiprazolum 400 mg ut aripiprazolum monohydricum, carmellosum natricum, mannitolum, natrii dihydrogenophosphas monohydricus, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 2 ml corresp. natrium max. 2.2 mg. | | Packungsbestandteile | | Praeparatio cryodesiccata: | | | Depot-Injektionssuspension in einer Fertigspritze | | | | | | | | Active Agent | Dose |
|---|
| Aripiprazolum | 400 mg |
| | BAG: Active Agent | Dose |
|---|
| Aripiprazolum | 400 mg |
| | | | Inactive agents |
|---|
| Carmellosum Natricum | | Mannitolum | | Natrii Dihydrogenophosphas Monohydricus | | Natrii Hydroxidum |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | Fertigspritze(n) | 271.72 | 311.95 | B | SL | Yes |
|
|
